OpView image processing software reconstructs breast images obtained from full-field digital mammography, as well as ultrasound and MRI, to bring clarity to challenging breast scans. The software, unveiled Sunday at the RSNA meeting by Siemens Medical Solutions, will assist interpretation of lesions in dense breasts and microcalcifications, according to the company.
OpView image processing software reconstructs breast images obtained from full-field digital mammography, as well as ultrasound and MRI, to bring clarity to challenging breast scans. The software, unveiled Sunday at the RSNA meeting by Siemens Medical Solutions, will assist interpretation of lesions in dense breasts and microcalcifications, according to the company.
Running in concert with visualization features built into Siemens' syngo-based workstations, OpView can be used to adjust the display of images to concentrate on areas of high interest, such as the borders of the breast and subtle masses, or to adjust brightness and contrast for optimal display of images.
The software decreases the quantum and electronic noise from x-rays that can interfere with the evaluation of suspicious lesions, particularly abnormalities that are low in contrast. An edge enhancement feature enhances high frequencies in an image to increase the visibility of structures such as microcalcifications.
In addition to the multimodality Mammomat Novation syngo-based acquisition workstation, OpView can be used with the MammoReport workstation, which incorporates computer-aided detection (CAD) markers from various vendors.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.